
GC61291
SPR719
Also known as 1-ethyl-3-[5-fluoro-6-[2-(2-hydroxypropan-2-yl)pyrimidin-5-yl]-4-[(2R)-oxolan-2-yl]-1H-benzimidazol-2-yl]urea
SPR719 (VXc-486) is a gyrase B inhibitor, with bactericidal activity
ChemicalCAS1384984-18-2MW428.46FormulaC21H25FN6O3
- CAS number
- 1384984-18-2
- Molecular weight
- 428.46
- Formula
- C21H25FN6O3
- Solubility
- DMSO : 20 mg/mL (46·68 mM; ultrasonic and adjust pH to 2 with HCl)
- InChIKey
- BKUISYCLLXCBJV-CQSZACIVSA-N
- Catalogue number
- GC61291
- Brand
- GLPBIO
Computed properties PubChem CID 57524959 · XLogP 1.1 · TPSA 125 Ų · H-bond donors 4
- XLogP
- 1.1
- TPSA
- 125 Ų
- H-bond donors
- 4
- H-bond acceptors
- 7
- Rotatable bonds
- 5
- Heavy atoms
- 31
SMILES CCNC(=O)NC1=NC2=C(N1)C=C(C(=C2[C@H]3CCCO3)F)C4=CN=C(N=C4)C(C)(C)O
Computed descriptors from PubChem (CID 57524959), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il